Oct 2023 $33 M No. 4 $10 to $50 million 72
DermBiont, Inc.: Raise no. 4, Oct 2023 × Investors in this round 72 investors had bought by the notice of Nov 13, 2024: 72 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $33 M of $45 M offered; $13 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl R. Beutner · Executive Officer, Director Max R. Dawson · Executive Officer Nichola R. Eliovits · Executive Officer, Director Daniel R. Yadegar · Director Steven R. Basta · Director Wilder R. Ramsey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “$21,388,728.28 new money; up to $12,615,602.32 in pay-to-play second closing; $2,052,390.94 conversion of SAFEs; $9,255,961.88 conversion of notes”Signed by Karl R. Beutner, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Nov 13, 2024. Read the notice at the SEC .
equity, options SEC Dec 2021 $29 M No. 3 $10 to $50 million 42
DermBiont, Inc.: Raise no. 3, Dec 2021 × Investors in this round 42 investors had bought by the notice of Dec 29, 2021: 42 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $29 M of $40 M offered; $11 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl R. Beutner · Executive Officer, Director Max R. Dawson · Executive Officer Nichola R. Eliovits · Executive Officer Jennifer R. Lee · Director Steven R. Basta · Director Wilder R. Ramsey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Nichola Eliovits, Chief Business Officer. Source: SEC Form D, newest notice filed Dec 29, 2021. Read the notice at the SEC .
equity SEC Aug 2021 $19 M Issued in a merger or acquisition $10 to $50 million 9
DermBiont, Inc.: Private sale, Aug 2021 × Investors in this round 9 investors had bought by the notice of Aug 19, 2021: 9 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $19 M of $19 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl R. Beutner · Executive Officer, Director Nichola R. Eliovits · Executive Officer, Director Robert R. Brucker · Executive Officer Jennifer R. Lee · Director Steven R. Basta · Director Wilder R. Ramsey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Nichola Eliovits, Chief Business Officer. Source: SEC Form D, newest notice filed Aug 19, 2021. Read the notice at the SEC .
equity SEC Feb 2021 $7 M No. 2 $2 to $10 million 19
DermBiont, Inc.: Raise no. 2, Feb 2021 × Investors in this round 19 investors had bought by the notice of Feb 24, 2021: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $15 M offered; $8 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl R. Beutner · Executive Officer, Director Nichola R. Eliovits · Executive Officer, Director Robert R. Brucker · Executive Officer Steven R. Basta · Director Wilder R. Ramsey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Nichola Eliovits, Chief Business Officer. Source: SEC Form D, newest notice filed Feb 24, 2021. Read the notice at the SEC .
debt, options SEC Oct 2020 $7 M Issued in a merger or acquisition $2 to $10 million 19
DermBiont, Inc.: Private sale, Oct 2020 × Investors in this round 19 investors had bought by the notice of Oct 30, 2020: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $8 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last more than a year
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl R. Beutner · Executive Officer, Director Nichola R. Eliovits · Executive Officer, Director Robert R. Brucker · Executive Officer Steven R. Basta · Director Wilder R. Ramsey · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Nichola Eliovits, Chief Business Officer. Source: SEC Form D, newest notice filed Oct 30, 2020. Read the notice at the SEC .
equity SEC May 2019 $9 M No. 1 $2 to $10 million 42
DermBiont, Inc.: Raise no. 1, May 2019 × Investors in this round 42 investors had bought by the notice of Jun 11, 2019: 42 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $9 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Karl R. Beutner · Executive Officer, Director Nichola R. Eliovits · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Karl R. Beutner, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 11, 2019. Read the notice at the SEC .
equity SEC